TTC Logo
     The Curated & Collaborative Cancer Drug Database
 
Home•  About•  Compounds•  Expert Opinion•  Trial Analysis•  Pathways•  Cancer Types•  Workspace • Features smartlink Bookmark and Share  

 

 

 

 

Log In  or  Register

 

 

 

 

 

 

 

 

 

FOR MORE INFO

 

OR TO SCHEDULE A DEMO

 

CALL TOLL FREE

 

1-877-882-1124

 

or

 

CLICK HERE

 

 

 

 

 

 

 

 

 

Follow curabaseinfo on Twitter

 

 

    


• Take Advantage of Curated Data on Over 500 Novel Cancer Drugs

 

• Query Clinical Trial Results from 100s of Studies  

 

• Annotate Database Content

 

• Share Information and Comments with Others

CuraBase Sign-up Button

 

Access to CuraBase® is free-of-charge for users in Academia or Non-Profit Organizations.

Click Here To Register 

                                
 

Subscribers Get:

Comprehensive Information on

Cancer Drugs in Development  

 

The CuraBase® database contains

information on 100s of compounds.

These include FDA approved agents

as well as compounds currently

undergoing preclinical or

clinical evaluation.     

  CuraBase Cancer Drug Listing

Focus Topic This Month:

 

New Data From the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Berlin, 2011

 

- XL184 - promising activity in HCC, Prostate cancer. Data now in our database.

 

 

 

 

 

Subscribers Get:

Detailed Clinical Trials Results  

     

CuraBase®, a relational database, allows users to easily search and display detailed data in a compact and clear output format.

  CuraBase Clinical Trial Results

Recently Updated:

 

Phase I Trial of the Irreversible EGFR and HER2 Kinase
Inhibitor BIBW 2992 in Patients With Advanced
Solid Tumors

 

Veliparib (Abbot)

 

AS605240 (Merck-Serono)

 

 

 

 

Subscribers Can:

Compile Clinical Trial Data       

 

Easily generate your comprehensive tables summarizing clinical trial results by compound class or tumor type.

  CuraBase Clinical Cancer Trial Results Compilation

Experts and Consulting Solutions

 

CuraBase® provides access to a network of renowned experts.

 

Using integrated annotation and blogging features, expert commentary can be shared among users.

 

Subscribers Can:

Annotate and Share

      

CuraBase® allows users to add their own content and share this information with others in a password-protected space - add and share your own, proprietary layer of information!

  Curabase user annotation and commenting feature
 
 

Subscribers Get:

Molecular Pathways

      

View compounds mapped onto molecular pathways.

  CuraBase cancer pathway drug mapping

CuraBase® workswell on

 

iPhone® and iPad®*

 

 

curabase guarantee
 

FREE ACCESS WITHOUT SUBSCRIPTION:

 

Molecular Changes in Cancer

      

A comprehensive, systematic collection of molecular aberrations in a large number of cancer types.

Click Here For Molecular Data

  Curabase Recurrent Cancer Mutations lists
 
 
 
 
Click Here to Learn More about CuraBase Features